DE69213554T2 - Neue Steroidderivate von Pregna-4,9(11),17(20)-trien-3-on, ihre Herstellung, ihre Verwendung zur Herstellung von Derivaten des Typs Pregna-4,9(11),16-trien-3,20-dion und neue Zwischenprodukte - Google Patents

Neue Steroidderivate von Pregna-4,9(11),17(20)-trien-3-on, ihre Herstellung, ihre Verwendung zur Herstellung von Derivaten des Typs Pregna-4,9(11),16-trien-3,20-dion und neue Zwischenprodukte

Info

Publication number
DE69213554T2
DE69213554T2 DE69213554T DE69213554T DE69213554T2 DE 69213554 T2 DE69213554 T2 DE 69213554T2 DE 69213554 T DE69213554 T DE 69213554T DE 69213554 T DE69213554 T DE 69213554T DE 69213554 T2 DE69213554 T2 DE 69213554T2
Authority
DE
Germany
Prior art keywords
preparation
pregna
trien
derivatives
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69213554T
Other languages
English (en)
Other versions
DE69213554D1 (de
Inventor
Francis Brion
Jean Buendia
Christian Diolez
Michel Vivat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of DE69213554D1 publication Critical patent/DE69213554D1/de
Publication of DE69213554T2 publication Critical patent/DE69213554T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007—Cyclic thioketals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69213554T 1991-05-23 1992-05-20 Neue Steroidderivate von Pregna-4,9(11),17(20)-trien-3-on, ihre Herstellung, ihre Verwendung zur Herstellung von Derivaten des Typs Pregna-4,9(11),16-trien-3,20-dion und neue Zwischenprodukte Expired - Lifetime DE69213554T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR919106202A FR2676740B1 (fr) 1991-05-23 1991-05-23 Nouveaux derives sterouides du pregna-4,9(11),17(20)-trie-3-one, leur preparation, leur application a la preparation de composes sterouides de type pregna-4,9(11),16-triene-3,20-dione et nouveaux intermediaires.

Publications (2)

Publication Number Publication Date
DE69213554D1 DE69213554D1 (de) 1996-10-17
DE69213554T2 true DE69213554T2 (de) 1997-03-06

Family

ID=9413039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69213554T Expired - Lifetime DE69213554T2 (de) 1991-05-23 1992-05-20 Neue Steroidderivate von Pregna-4,9(11),17(20)-trien-3-on, ihre Herstellung, ihre Verwendung zur Herstellung von Derivaten des Typs Pregna-4,9(11),16-trien-3,20-dion und neue Zwischenprodukte

Country Status (17)

Country Link
US (7) US5187273A (de)
EP (1) EP0515264B1 (de)
JP (1) JP3037507B2 (de)
KR (1) KR100203323B1 (de)
CN (2) CN1034867C (de)
AT (1) ATE142638T1 (de)
CA (1) CA2069248C (de)
DE (1) DE69213554T2 (de)
DK (1) DK0515264T3 (de)
ES (1) ES2091420T3 (de)
FR (1) FR2676740B1 (de)
GR (1) GR3021335T3 (de)
HU (2) HU9203926D0 (de)
IE (1) IE76920B1 (de)
MX (1) MX9202434A (de)
TW (1) TW228003B (de)
UA (1) UA29395C2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen
FR2700339B1 (fr) * 1993-01-14 1995-03-03 Roussel Uclaf Nouveaux dérivés 17,20-époxydes du pregnane, leur préparation, leur application à la préparation de dérivés cortisoniques et intermédiaires.
FR2719588B1 (fr) * 1994-05-03 1996-06-07 Roussel Uclaf Nouveau procédé de préparation de la substance "S" et nouveaux intermédiaires.
CN100387611C (zh) * 2006-02-23 2008-05-14 中国科学院上海有机化学研究所 一类16α-溴代甾体化合物及其合成方法
CN100398553C (zh) * 2006-07-24 2008-07-02 汪家振 游离甲地孕酮的化学合成方法
CN101250211B (zh) * 2008-04-02 2010-12-22 中国科学院上海有机化学研究所 一类孕甾-16-烯-20s-乙酸酯化合物及其合成方法
CN104328159A (zh) * 2014-10-21 2015-02-04 江西赣亮医药原料有限公司 一种1,4,9(11)-三烯雄甾-3,17-二酮的制备方法
CN106946964A (zh) * 2017-05-04 2017-07-14 山东赛托生物科技股份有限公司 一种含有双键的甾核衍生物的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2744109A (en) * 1955-01-13 1956-05-01 Searle & Co 3-ethylene mercaptoles of 21-hydroxy-4-pregnene-3, 20-dione, its 17-hydroxy derivative and esters thereof
US2744108A (en) * 1955-01-13 1956-05-01 Searle & Co 3-ethylene mercaptoles of 11-oxygenated derivatives of 17, 21-dihydroxy-4-pregnene-3, 20-diones
FR1241109A (fr) 1955-06-30 1960-09-16 American Cyanamid Co Procédé de préparation de nouveaux composés de stéroïdes, notamment les 9alphahalogéno-16alpha-hydroxy-hydrocortisones et esters de celles-ci, et les oxydes 9bêta, 11 bêta de delta-prégnènes
US3023229A (en) 1958-09-08 1962-02-27 Searle & Co Microbiological aromatization of steroids
US3493563A (en) * 1968-02-23 1970-02-03 Squibb & Sons Inc Process for the production of intermediates for triamcinolone and related compounds
US3707537A (en) * 1969-01-08 1972-12-26 Hoffmann La Roche 4-chloro-4,6-diene-6-halo or lower alkyl steroids
HU162303B (de) * 1970-09-30 1973-01-29
LU77457A1 (de) * 1977-05-31 1979-01-19
US4216159A (en) * 1978-05-25 1980-08-05 The Upjohn Company Synthesis of 16-unsaturated pregnanes from 17-keto steroids
US4189430A (en) * 1978-07-31 1980-02-19 The Upjohn Company Epoxide process
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
GB2046755B (en) * 1979-03-12 1983-01-12 Upjohn Co Metalating olefines
DE3109459A1 (de) * 1981-03-09 1982-09-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen (delta)(pfeil hoch)9(pfeil hoch)(pfeil hoch)((pfeil hoch)(pfeil hoch)1(pfeil hoch)(pfeil hoch)1(pfeil hoch)(pfeil hoch))(pfeil hoch)- und (delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch)6(pfeil hoch)-21-chlor-20-keto-steroide der pregnan- und d-homo-pregnan-reihe, verfahren zu ihrer herstellung und ihre verwendung als zwischenprodukte fuer die synthese von hochwirksamen corticoiden
US4357279A (en) * 1981-05-18 1982-11-02 The Upjohn Company Preparation of corticoids from 17-keto steroids
EP0123735A1 (de) * 1983-04-29 1984-11-07 Gist-Brocades N.V. Verfahren zur Herstellung von 20-keto-delta-16-Steroiden und in diesem Verfahren erhaltene Zwischenprodukte
EP0123736A1 (de) * 1983-04-29 1984-11-07 Gist-Brocades N.V. Verfahren zur Herstellung von 21-Hydroxy-20-keto-delta-16-steroiden und in diesem Verfahren erhaltene Zwischenprodukte
DE3852252T2 (de) * 1987-09-11 1995-04-06 Nippon Zeon Co Verfahren zur Herstellung einer alpha-acyloxy-alpha-beta-ungesättigten Verbindung und eines 20-acyloxy-17(20)-methylen-21-al-steroidderivats.
AU618350B2 (en) * 1988-04-08 1991-12-19 Aventis Pharma S.A. 9-alpha-hydroxy-17-methylene steroids, process for their preparation and their use in the preparation of corticosteroids

Also Published As

Publication number Publication date
MX9202434A (es) 1992-11-01
HU9201715D0 (en) 1992-08-28
FR2676740B1 (fr) 1993-11-05
US5502223A (en) 1996-03-26
US5187273A (en) 1993-02-16
US5594127A (en) 1997-01-14
HU9203926D0 (en) 1993-03-29
US5401864A (en) 1995-03-28
CA2069248C (fr) 2004-07-13
US5756722A (en) 1998-05-26
CN1034867C (zh) 1997-05-14
HU212309B (en) 1996-05-28
ATE142638T1 (de) 1996-09-15
EP0515264B1 (de) 1996-09-11
EP0515264A2 (de) 1992-11-25
JPH05178886A (ja) 1993-07-20
CN1140177A (zh) 1997-01-15
UA29395C2 (uk) 2000-11-15
IE921669A1 (en) 1992-12-02
TW228003B (de) 1994-08-11
FR2676740A1 (fr) 1992-11-27
KR920021577A (ko) 1992-12-18
KR100203323B1 (ko) 1999-06-15
GR3021335T3 (en) 1997-01-31
DK0515264T3 (da) 1996-10-07
CA2069248A1 (fr) 1992-11-24
EP0515264A3 (en) 1993-01-13
US5294704A (en) 1994-03-15
IE76920B1 (en) 1997-11-05
HUT63174A (en) 1993-07-28
JP3037507B2 (ja) 2000-04-24
ES2091420T3 (es) 1996-11-01
CN1043426C (zh) 1999-05-19
CN1066852A (zh) 1992-12-09
DE69213554D1 (de) 1996-10-17
US5760256A (en) 1998-06-02

Similar Documents

Publication Publication Date Title
PT75294A (de) Neue 6 alpha-methylprednisolon-derivate ihre herstellung und verwendung
BRPI9915679A8 (pt) Composições e métodos para aumentar a mineralização óssea
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
ATE29265T1 (de) Neue redox-indikatoren.
NZ331941A (en) Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69213554T2 (de) Neue Steroidderivate von Pregna-4,9(11),17(20)-trien-3-on, ihre Herstellung, ihre Verwendung zur Herstellung von Derivaten des Typs Pregna-4,9(11),16-trien-3,20-dion und neue Zwischenprodukte
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
HUP0003484A2 (hu) Pirrolidin-3-karbonsav-származékok és alkalmazásuk endotelin antagonistaként
ATE28651T1 (de) Neue 6alpha-methylkortikoide, ihre herstellung und verwendung.
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69402441T2 (de) Neue 17,20-Epoxyd Derivate von Pregnan, ihre Verwendung zur Herstellung von Cortison-Derivaten und Zwischenprodukte dafür
ATE12487T1 (de) Chlorierte betaketoester, ihre herstellung und anwendung.
DE3568424D1 (en) Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
DE68911237D1 (de) Nichtionische Trijodbenzin-Verbindungen und diese enthaltende Kontrastmittel.
ES2162932T3 (es) Derivados de estreptogramina, su preparacion y las composiciones farmaceuticas que les contienen.
DE69222947D1 (de) Reinigung von faktor xiii
SE8601344L (sv) Derivat av 11-desoxi-17alfa-hydroxikortikosteron
EP0297620A3 (de) Verfahren zur Herstellung bicyclischer Aminocarbonsäuren, Zwischenprodukte dieses Verfahrens und deren Verwendung
ATE77744T1 (de) Verwendung von pyrrothinderivaten.
FI960929A (fi) Välituotteena käyttökelpoiset indolonijohdannaiset

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HOECHST MARION ROUSSEL, PUTEAUX, FR

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

R071 Expiry of right

Ref document number: 515264

Country of ref document: EP